Brevan Howard Capital Management’s Constellation Brands STZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81M Buy
27,407
+15,882
+138% +$2.36M 0.03% 448
2026
Q1
$1.73M Buy
+11,525
New +$1.78M 0.02% 627
2025
Q4
– Sell
-33,646
Closed -$4.53M – 2258
2025
Q3
$4.53M Buy
33,646
+17,246
+105% +$2.74M 0.02% 259
2025
Q2
$2.67M Buy
+16,400
New +$2.94M 0.02% 621
2025
Q1
– Sell
-35,812
Closed -$7.91M – 1446
2024
Q4
$7.91M Buy
+35,812
New +$8.51M 0.05% 90
2024
Q3
– Sell
-2,387
Closed -$614K – 1424
2024
Q2
$614K Buy
+2,387
New +$614K 0.01% 537
2024
Q1
– Sell
-5,717
Closed -$1.38M – 1337
2023
Q4
$1.38M Buy
5,717
+3,953
+224% +$940K 0.02% 173
2023
Q3
$443K Buy
+1,764
New +$461K 0.01% 188

Other funds holding STZ

Brevan Howard Capital Management's STZ Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Constellation Brands (STZ) stake by 138% in Q2 2026, buying an estimated $2.36M and bringing the position to 27,407 shares worth $3.81M. The position accounts for 0.03% of the portfolio, ranked #448.

Brevan Howard Capital Management first reported a position in STZ in Q3 2023 and has held it in 8 quarters since. The position peaked at $7.91M in Q4 2024. 1,036 funds tracked by Wall St. Rank hold STZ as of Q2 2026.

  • Brevan Howard Capital Management held 27,407 shares of Constellation Brands worth $3.81M as of Q2 2026.
  • Brevan Howard Capital Management bought 15,882 Constellation Brands shares in Q2 2026, an estimated $2.36M.
  • Constellation Brands made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #448 holding.
  • Brevan Howard Capital Management first reported a position in Constellation Brands in Q3 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Constellation Brands position peaked at $7.91M in Q4 2024.
  • 1,036 funds tracked by Wall St. Rank held Constellation Brands as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.